Andy clark, manager of the finsbury life sciences iT, believes the sector is cheap because it is being priced like tech stocks
Andy Clark, manager of the £34m Finsbury Life Sciences investment trust, says prices for biotech stocks are now so cheap that he is employing an element of gearing in the trust for the first time in its five year life. Clark says the prices of companies have fallen so far that he wants to use all the 'fire power' he has. He has increased the level of gearing to around 2% and expects that will reach as high as 5%-7% in coming weeks. Until now, Clark has not used gearing in the trust as he considers this to be a high-risk move given the volatility of the underlying holdings. There was a p...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes